Toronto Transplant Hepatology Fellowship Co Director, Dr. Zita Galvin, will speak at the CST-CTRMS Scientific Meeting on September 27th at 9:40 am in the Liver Concurrent Session (Suite 202) “Predictors of de novo NAFLD post liver...
Dr. Bhat won the Vanguard award for her publication, “Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.” Summary: Patients listed with exception points for hepatocellular...
